Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

1.90
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.68
Today|||52-Week Range
7.15
-68.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$473.6M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel gastrointestinal therapies. Its product includes plecanatide and dolcanatide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610

Employees

Shareholders

Individual stakeholders7.53%
Other institutional39.56%
Mutual fund holders23.72%

Top Executives

Gary S. JacobChairman, President & Chief Executive Officer
Laura BarrowSenior Vice President-Clinical Operations
Gary G. GemignaniChief Financial Officer & Executive Vice President
Patrick H. GriffinChief Medical Officer & Executive Vice President
Chhaya ShahSenior VP-Manufacturing & Technical Operations